Erchonia Corporation was founded in 1996 as a small family business, and even though it has grown into an international enterprise, it still operates under the founding principles that guided it to success. Erchonia's commitment to the legitimate advancement of Low Level Laser Therapy (3LT) through scientific and clinical research has transformed it into a world leader in the field of 3LT technology. The integrity, diligence, quality and commitment of the company are evident in the rigorous process it follows in order to take a research hypothesis from concept to viable, agency-approved product and treatment method. To ensure a steadfast adherence to its unique, all-encompassing approach, the company serves as manufacturer, marketer, developer, promoter, creator and user of all its products.